ConjuChem Biotechnologies Inc. (TSX:CJB) is pleased to announce that it has filed a preliminary short form prospectus with the securities regulatory authorities in each of the provinces of Canada and signed an underwriting and agency agreement pursuant to which the underwriters have agreed to (i) purchase 57,690,000 units of ConjuChem at a price of $0.65 per unit and (ii) offer on a best effort basis up to a maximum of 127,310,000 additional units on the same terms. Each unit consists of one common share of ConjuChem and one half of a common share purchase warrant. Each whole warrant will entitle its holder to purchase one common share for a period of 3 years from the closing of the offering at a purchase price of $1.00 per share.
